Results 81 to 90 of about 347,425 (170)

Current evidence for treatment with nusinersen for spinal muscular atrophy : a systematic review [PDF]

open access: yes, 2019
Recent discovery of nusinersen, an antisense oligonucleotide drug, has provided encouragement for improving treatment of spinal muscular atrophy. No therapeutic options currently exist for this autosomal recessive motor neuron disorder.
Meylemans, Antoon, De Bleecker, Jan
core   +1 more source

Cross-examining candidate genes implicated in multiple system atrophy

open access: yesActa Neuropathologica Communications, 2019
Multiple system atrophy (MSA) is a devastating neurodegenerative disease characterized by the clinical triad of parkinsonism, cerebellar ataxia and autonomic failure, impacting on striatonigral, olivopontocerebellar and autonomic systems.
Jared S. Katzeff   +4 more
doaj   +1 more source

Linking the cerebellum posterior lobules atrophy to multiple system atrophy cognitive impairment

open access: yesNeurobiology of Disease
Background: Cognitive impairments in multiple system atrophy (MSA) are linked to cerebellar dysfunction, but the role of specific posterior cerebellar lobules in domain-specific deficits remains unclear.
Huaguang Yang   +6 more
doaj   +1 more source

Can a Type-2 Diabetes Mellitus drug be hope for Multiple System Atrophy?

open access: yesAdvances in Clinical Neuroscience & Rehabilitation, 2020
Demir, Yeliz
doaj   +1 more source

A mouse model of adult-onset multiple system atrophy

open access: yesNeurobiology of Disease, 2019
Multiple system atrophy (MSA) is an adult-onset neurodegenerative disorder clinically characterized by autonomic failure in addition to various combinations of symptoms of parkinsonism, cerebellar ataxia, and pyramidal dysfunction.
Kunikazu Tanji   +7 more
doaj   +1 more source

Schizophrenia is a TH2 dominant autoimmune disease possibly against acetylcholine receptors of CNS [PDF]

open access: yes, 2012
Schizophrenia is a very common psychiatric disorder. However, its etiology and pathogenesis is still unknown. Current theory saying that neurotransmitter imbalance such as serotonin or dopamine only provides limited effectiveness in schizophrenia ...
Wanchung(Wan-Jiung) Hu
core   +1 more source

Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. [PDF]

open access: yes, 2014
Macroautophagy (hereafter autophagy) is a key pathway in neurodegeneration. Despite protective actions, autophagy may contribute to neuron demise when dysregulated.
Batlevi, Yakup   +11 more
core  

Cognitive impairment in multiple system atrophy: Changing concepts

open access: yesDementia & Neuropsychologia
Multiple system atrophy (MSA) is characterized by a variable combination of cerebellar ataxia, parkinsonism and pyramidal signs associated with autonomic failure. Classically, cognitive impairment was not considered a clinical feature of MSA and dementia
Agessandro Abrahão   +5 more
doaj   +1 more source

Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. [PDF]

open access: yes, 2018
Alzheimer's disease (AD), the most common form of dementia, is characterized by the abnormal accumulation of amyloid plaques and hyperphosphorylated tau aggregates, as well as microgliosis. Hemizygous missense variants in Triggering Receptor Expressed on
Akassoglou, Katerina   +15 more
core   +1 more source

Editorial: Autonomic dysfunction in multiple system atrophy

open access: yesFrontiers in Neurology, 2022
Tatsuya Yamamoto   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy